← Open Payments lookup

HA LE: Open Payments

NPI 1407410400 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$348 in 14 payments from 4 companies in 2025. Trend: 2023 $820 · 2024 $510 · 2025 $348

Food & beverage: $348
CompanyPaymentsAmount
Smith+Nephew, Inc.5$138
ABBVIE INC.5$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$79
GlaxoSmithKline, LLC.1$27

Products named: COLLAGENASE SANTYL, CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, LINZESS, CREON.

Industry payments across CA — which companies pay providers there.